EUR-Lex Search results

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Search Results

Sort by

Written question P-004579/14 Ingeborg Gräßle (PPE) to the Commission. Disappearance of EU funding for the Luckenwalde-based Human BioSciences (HBS) wound care dressing factory

CELEX number:
92014E004579
Form:
Written question
Author:
European Parliament, Not available
Date of document:
11/04/2014; Date of transmission
Number of pages:
2

Written question E-002133/14 Philippe De Backer (ALDE) to the Commission. Action plan on the competitiveness of the pharmaceutical sector

CELEX number:
92014E002133
Form:
Written question
Author:
European Parliament, Not available
Date of document:
24/02/2014; Date of transmission
Number of pages:
2

Written question E-002918/14 Gilles Pargneaux (S&D) to the Commission. Avastin — illicit collusion between Swiss pharmaceutical companies

CELEX number:
92014E002918
Form:
Written question
Author:
European Parliament, Not available
Date of document:
12/03/2014; Date of transmission
Number of pages:
2

Written question E-000665/14 Csanád Szegedi (NI) to the Commission. Handling healthcare data and the abuse of such

CELEX number:
92014E000665
Form:
Written question
Author:
European Parliament, Not available
Date of document:
23/01/2014; Date of transmission
Number of pages:
2

Written question E-000935/14 Claudiu Ciprian Tănăsescu (S&D) to the Commission. Access to palliative care

CELEX number:
92014E000935
Form:
Written question
Author:
European Parliament, Not available
Date of document:
30/01/2014; Date of transmission
Number of pages:
2

Written question E-000408/14 Susy De Martini (ECR) to the Commission. Explanations of the meetings and financial relations between the Commission and interest groups during the preparatory stage of the Tobacco Products Directive

CELEX number:
92014E000408
Form:
Written question
Author:
European Parliament, Not available
Date of document:
16/01/2014; Date of transmission
Number of pages:
3

Written question E-014092/13 Cornelis de Jong (GUE/NGL) to the Commission. Fines for Janssen-Cilag and Sandoz

CELEX number:
92013E014092
Form:
Written question
Author:
European Parliament, Not available
Date of document:
12/12/2013; Date of transmission
Number of pages:
2

Written question E-005053/13 Diogo Feio (PPE) to the Commission. Legal action against the pharmaceutical company Novartis in the United States

CELEX number:
92013E005053
Form:
Written question
Author:
European Parliament, Not available
Date of document:
07/05/2013; Date of transmission
Number of pages:
2

Written question E-006056/13 Anna Rosbach (ECR) to the Commission. Rules regarding gifts from companies in the pharmaceutical and medical devices sectors

CELEX number:
92013E006056
Form:
Written question
Author:
European Parliament, Not available
Date of document:
30/05/2013; Date of transmission
Number of pages:
2

Written question E-003999/13 Ramon Tremosa i Balcells (ALDE) to the Commission. The situation of the Catalan pharmacy industry and Directive 2011/7/EU on late payment

CELEX number:
92013E003999
Form:
Written question
Author:
European Parliament, Not available
Date of document:
10/04/2013; Date of transmission
Number of pages:
3
Sort by
2
Domain: All, Subdomain: Parliamentary questions, EUROVOC descriptor: pharmaceutical industry, Search language: English